Recent Comments

Comment RSS

Search results for 'Doxazosin'


Diuretic drug works best at reducing risk of heart failure in hypertension New research supports the findings of a landmark drug comparison study published in 2002 in which a diuretic drug or "water pill" outperformed other medications for high blood pressure. A scientific team including investigators from The University of Texas Health Science Center at Houston reports the findings in the May 11 issue of the Archives of Internal Medicine. http://www.news-medical.net/news/2009/05/13/Diuretic-drug-works-best-at-reducing-risk-of-heart-failure-in-hypertension.aspx
Diuretic reduces risk for type of heart failure that affects women more often than New research by The University of Texas School of Public Health shows that a medication for high blood pressure called a diuretic or water pill is particularly effective at reducing the risk for a type of heart failure that affects women more often than men. http://www.news-medical.net/news/2008/11/11/42808.aspx
Evidence strongly supports diuretics as initial metabolic syndrome therapy, especially in black patients New research shows that in people with high blood pressure as part of metabolic syndrome, a cluster of conditions that increases the risk for heart disease, diuretics offer greater protection against cardiovascular disease, including heart failure, and are at least as effective for lowering blood pressure as newer, more expensive medications. http://www.news-medical.net/news/2008/01/28/34750.aspx
Gene variations associated with effectiveness of blood pressure medications Patients with hypertension and certain gene variations experienced varying results with some blood pressure medications, suggesting matching a patient's genotype with certain hypertension medications could result in more favorable outcomes, according to a study in the January 23 issue of JAMA: The Journal of the American Medical Association. http://www.news-medical.net/news/2008/01/23/34640.aspx
Prostate drug doxazosin blocks receptor in heart muscle, increasing risk of heart failure Doxazosin, a drug commonly prescribed to help improve urinary flow in men with enlarged prostates, increases the likelihood of heart failure by blocking specific receptors in heart muscle cells, according to a study conducted at the San Francisco VA Medical Center. http://www.news-medical.net/news/2006/04/04/17106.aspx
Study to compare prostate surgery and drugs The Minimally Invasive Surgical Therapies (MIST) Consortium for Benign Prostatic Hyperplasia (BPH) has launched a new study to compare long-term benefits and risks of transurethral needle ablation (TUNA) and transurethral microwave thermotherapy (TUMT) to a regimen of the alpha-1 inhibitor alfuzosin and the 5-alpha reductase inhibitor finasteride. http://www.news-medical.net/news/2004/08/20/4210.aspx
FDA Approves PROSCAR® Combined With Doxazosin to Reduce the Risk of Benign Prostatic Hyperplasia Symptoms Merck & Co., Inc. today announced that the Food and Drug Administration (FDA) has approved changes to the prescribing information for PROSCAR® (finasteride) based on a landmark National Institutes of Health (NIH) study. http://www.news-medical.net/news/2004/04/20/686.aspx
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.